Triamcinalone
Type 2 Diabetes Mellitus (T2DM)
Haydarpasa Numune Training and Research HospitalActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Type 2 Diabetes Mellitus (T2DM) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Enicepatide Hoffmann-La Roche | Phase 3 | BB |
met097 Pfizer | Phase 2 | B |
ck-0045 Cytoki Pharma | Phase 2 | CCC |
mkp10241 Mankind Pharma Limited | Phase 2 | CCC |
pg-102 ProGen. Co., Ltd. | Phase 2 | CCC |
View all 13 →
Same molecule, other indications
Triamcinalone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →